Primary |
Product Used For Unknown Indication |
44.1% |
Coronary Artery Bypass |
18.2% |
Drug Use For Unknown Indication |
13.5% |
Cardiac Operation |
6.4% |
Aortic Valve Replacement |
4.2% |
Mitral Valve Replacement |
2.4% |
Catheterisation Cardiac |
2.3% |
Mitral Valve Repair |
1.7% |
Hypertension |
1.4% |
Surgery |
0.9% |
Tricuspid Valve Repair |
0.8% |
Aortic Surgery |
0.6% |
Diabetes Mellitus |
0.5% |
Pain |
0.5% |
Aortic Aneurysm Repair |
0.4% |
Cardiopulmonary Bypass |
0.4% |
Heart Transplant |
0.4% |
Intra-aortic Balloon Placement |
0.4% |
Aortic Dissection |
0.4% |
Cox-maze Procedure |
0.4% |
|
Unevaluable Event |
47.8% |
Injury |
7.2% |
Pain |
6.7% |
Renal Failure |
5.7% |
Fear |
4.7% |
Anxiety |
4.0% |
Anhedonia |
3.9% |
Stress |
3.3% |
Emotional Distress |
3.0% |
Renal Injury |
2.6% |
Renal Failure Acute |
2.4% |
Depression |
2.0% |
Renal Impairment |
1.6% |
Death |
1.1% |
Multi-organ Failure |
1.1% |
Nervousness |
0.8% |
Cerebrovascular Accident |
0.8% |
Fear Of Death |
0.5% |
Disability |
0.4% |
Psychiatric Symptom |
0.3% |
|
Secondary |
Product Used For Unknown Indication |
56.9% |
Coronary Artery Bypass |
14.9% |
Aortic Valve Replacement |
5.9% |
Mitral Valve Replacement |
3.7% |
Catheterisation Cardiac |
3.3% |
Mitral Valve Repair |
2.8% |
Tricuspid Valve Repair |
1.7% |
Cardiac Operation |
1.7% |
Hypertension |
1.5% |
Aortic Surgery |
1.0% |
Intra-aortic Balloon Placement |
0.9% |
Sternotomy |
0.8% |
Heart Transplant |
0.8% |
Aortic Aneurysm Repair |
0.8% |
Cox-maze Procedure |
0.7% |
Diabetes Mellitus |
0.6% |
Atrial Septal Defect Repair |
0.6% |
Ventricular Assist Device Insertion |
0.6% |
Aortic Valve Repair |
0.5% |
Pain |
0.5% |
|
Injury |
14.2% |
Pain |
13.5% |
Unevaluable Event |
11.3% |
Fear |
8.4% |
Anxiety |
8.2% |
Anhedonia |
7.9% |
Renal Failure |
5.9% |
Emotional Distress |
5.1% |
Stress |
4.7% |
Depression |
3.8% |
Renal Impairment |
3.4% |
Renal Injury |
3.4% |
Renal Failure Acute |
2.3% |
Death |
1.9% |
Multi-organ Failure |
1.9% |
Cerebrovascular Accident |
1.3% |
Disability |
0.8% |
Nervousness |
0.7% |
Psychiatric Symptom |
0.6% |
Fear Of Death |
0.5% |
|
Concomitant |
Drug Use For Unknown Indication |
17.5% |
Liver Transplant |
12.5% |
Haemorrhage |
10.8% |
Haemostasis |
10.0% |
Prophylaxis |
7.5% |
Antibiotic Prophylaxis |
6.7% |
Anaesthesia |
5.0% |
Sedation |
4.2% |
Arrhythmia |
3.3% |
Fluid Imbalance |
3.3% |
Antibiotic Level |
2.5% |
Anticoagulant Therapy |
2.5% |
Operative Haemorrhage |
2.5% |
Analgesia |
1.7% |
Constipation |
1.7% |
Disseminated Intravascular Coagulation |
1.7% |
Dyspepsia |
1.7% |
Electrolyte Substitution Therapy |
1.7% |
Hyperglycaemia |
1.7% |
Hyperkalaemia |
1.7% |
|
Factor Viii Inhibition |
10.0% |
Septic Shock |
10.0% |
Thrombotic Stroke |
10.0% |
Medical Device Complication |
6.7% |
Pleural Haemorrhage |
6.7% |
Renal Failure Acute |
6.7% |
Tachyarrhythmia |
6.7% |
Alkalosis |
3.3% |
Death |
3.3% |
Generalised Oedema |
3.3% |
Hepatic Enzyme Increased |
3.3% |
Hepatotoxicity |
3.3% |
Liver Function Test Abnormal |
3.3% |
Pyrexia |
3.3% |
Rash |
3.3% |
Renal Vein Thrombosis |
3.3% |
Respiratory Failure |
3.3% |
Rhabdomyolysis |
3.3% |
Small Intestinal Haemorrhage |
3.3% |
Sternotomy |
3.3% |
|